Clinical Trial Update: Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the combination of neratinib and fam-trastuzumab deruxtecan for advanced gastric and gastroesophageal cancers, currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)
• Nerlynx (neratinib)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Gastric Cancer, Gastrointestinal Cancer | Phase 1 | Status: RECRUITING